Correlation Between Connect Biopharma and Cns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and Cns Pharmaceuticals, you can compare the effects of market volatilities on Connect Biopharma and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Cns Pharmaceuticals.
Diversification Opportunities for Connect Biopharma and Cns Pharmaceuticals
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Connect and Cns is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Cns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Connect Biopharma and Cns Pharmaceuticals
Given the investment horizon of 90 days Connect Biopharma Holdings is expected to generate 0.57 times more return on investment than Cns Pharmaceuticals. However, Connect Biopharma Holdings is 1.74 times less risky than Cns Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Cns Pharmaceuticals is currently generating about -0.21 per unit of risk. If you would invest 168.00 in Connect Biopharma Holdings on September 3, 2024 and sell it today you would lose (60.50) from holding Connect Biopharma Holdings or give up 36.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Connect Biopharma Holdings vs. Cns Pharmaceuticals
Performance |
| Timeline |
| Connect Biopharma |
| Cns Pharmaceuticals |
Connect Biopharma and Cns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Connect Biopharma and Cns Pharmaceuticals
The main advantage of trading using opposite Connect Biopharma and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.| Connect Biopharma vs. DiaMedica Therapeutics | Connect Biopharma vs. Lyra Therapeutics | Connect Biopharma vs. Centessa Pharmaceuticals PLC |
| Cns Pharmaceuticals vs. DiaMedica Therapeutics | Cns Pharmaceuticals vs. Lyra Therapeutics | Cns Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |